October 1, 2018

FDA Says CBD Does Not Meet Criteria For Federal Control. What Say You, DEA?

October 1, 2018
weed-3691738_1920
Thus begins a shift...starting with the first time in 46 years that the DEA has changed its stance on cannabis.

The Drug Enforcement Administration’s (DEA) recent decision to place GW Pharma’s cannabis-derived anti-epilepsy medication, Epidiolex, into its least restrictive category, Schedule 5, was based on a recommendation of the Food and Drug Administration (FDA), which had approved the drug in June.

According to a recently released internal government letter, reported Marijuana Moment, the FDA actually concluded that cannabidiol, or CBD, which is the primary ingredient in Epidiolex, does not meet the criteria for federal control at all.

It is important to note that while the FDA concluded that CBD should not be scheduled at all, the DEA classified only Epidiolex as a Schedule V drug while continuing to keep CBD itself under the most restrictive category of Schedule I, along with cannabis, heroin, and meth.

In order to bring Epidiolex to market, the FDA evaluated its medical utility and potential for abuse and then submit its findings to the DEA.

Meanwhile, the FDA concluded that CBD should not be scheduled by the DEA at all. Here’s why: “CBD and its salts… do not have a significant potential for abuse and could be removed from the [Controlled Substances Act],” the FDA wrote to the DEA in May.

Therefore, the FDA amended its recommendation, advising the DEA to place CBD in Schedule V, stating in a review that CBD has “negligible potential for abuse,” and a “currently accepted medical use in treatment” and abusing it “may lead to limited physical dependence” similar to other Schedule V drugs, reported Marijuana Moment.

Altogether, there were eight factors that the FDA considered when making its scheduling recommendation. “Upon consideration” of those eight factors, the agency said CBD alone “could be removed from control” under the CSA.

“We reach this conclusion because we find that CBD does not meet the criteria for placement in any of Schedules II, III, IV, or V under the CSA,” referring to the Controlled Substances Act, signed into law by President Richard Nixon on October 27, 1970.

In its conclusion, the FDA also reiterated that the scheduling of CBD should be “revisited promptly” if international treaty obligations change.

Thus begins a shift…starting with the first time in 46 years that the DEA has changed its stance on cannabis.

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on reddit
Reddit
Recent & Related Posts

Articles

Recent & Related Posts
Image of weed plant: Missouri has legal medical marijuana and is close to legalizing adult use cannabis.
Medical
Brodie Kush

Missouri Marijuana

Medical marijuana has been legalized in Missouri since 2018. As of the current date, recreational marijuana has yet to be legalized, however we are holding

Read More »
MisImage of Missouri medical marijuana program, but some patients have received fraudulent doctors' patient certifications.
Medical
Mark Willey

Missouri Medical Cannabis

Does Missouri Have Medical Cannabis? Yes. After voters passed Amendment 2 by an overwhelming margin in November 2018., Missouri voters showed their support behind MO

Read More »
Medical
Mark Willey

Missouri Green Doctors

Since voters passed Amendment 2 with an overwhelming majority in 2018, Missouri has become a new medical marijuana landscape and has seen approximately 50,000 patients

Read More »
Medical
Ryan Quinones

Hemp Missouri

Missourians have been growing hemp as a staple crop dating back to the early-nineteenth century. American farmers grew hemp all over the country and manufactured

Read More »